253 related articles for article (PubMed ID: 24333061)
61. Background rate of low-level HCV RNA in anti-HCV confirmed-positive and minipool nucleic acid test-nonreactive blood donations.
Groves JA; Y Dodd R; Zhu X; Linnen JM; Stramer SL
Transfusion; 2022 Jan; 62(1):143-150. PubMed ID: 34888879
[TBL] [Abstract][Full Text] [Related]
62. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
[TBL] [Abstract][Full Text] [Related]
63. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
64. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
65. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
66. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool?
Wang L; Chang L; Xie Y; Huang C; Xu L; Qian R; Zhu H; He Y; Li J; Huang H; Li W; Zhang K; Zhang R; Xie J; Sun Y; Li J
Transfusion; 2015 Feb; 55(2):395-404. PubMed ID: 25125223
[TBL] [Abstract][Full Text] [Related]
67. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
Kuhns MC; Busch MP
Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
[TBL] [Abstract][Full Text] [Related]
68. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
Tsoi WC; Lelie N; Lin CK
Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
[TBL] [Abstract][Full Text] [Related]
69. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
Grabarczyk P; van Drimmelen H; Kopacz A; Gdowska J; Liszewski G; Piotrowski D; Górska J; Kuśmierczyk J; Candotti D; Lętowska M; Lelie N; Brojer E
Transfusion; 2013 Oct; 53(10 Pt 2):2512-24. PubMed ID: 23590145
[TBL] [Abstract][Full Text] [Related]
70. Confirmation and follow up of initial "NAT yields": Prospective study from a tertiary healthcare center in India.
Pandey P; Tiwari AK; Dara RC; Rawat GS; Negi A; Raina V
Transfus Apher Sci; 2016 Apr; 54(2):242-7. PubMed ID: 26321477
[TBL] [Abstract][Full Text] [Related]
71. Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.
Chatterjee K; Coshic P; Borgohain M; Premchand ; Thapliyal RM; Chakroborty S; Sunder S
Natl Med J India; 2012; 25(4):207-9. PubMed ID: 23278777
[TBL] [Abstract][Full Text] [Related]
72. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV.
Ohnuma H; Tanaka T; Yoshikawa A; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Tomono T; Murozuka T; Takeda Y; Doi Y; Mine H; Yokoyama S; Hirose T; Nishioka K;
Microbiol Immunol; 2001; 45(9):667-72. PubMed ID: 11694079
[TBL] [Abstract][Full Text] [Related]
73. Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Phikulsod S; Oota S; Lin M; Saldanha J; Kleinman SH
Transfusion; 2011 Sep; 51(9):2012-22. PubMed ID: 21896033
[TBL] [Abstract][Full Text] [Related]
74. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
[TBL] [Abstract][Full Text] [Related]
75. [Blood Test Patterns for Blood Donors after Nucleic Acid Detection in the Blood Center].
Men SS; Lv LZ; Chen YF; Han CH; Liu HY; Yan Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1815-1819. PubMed ID: 29262922
[TBL] [Abstract][Full Text] [Related]
76. Clinical significance of viral markers testing by ELISA and Individual Donation Nucleic Acid Testing (ID-NAT) for blood screening in blood bank: Single center study in Egypt.
Attia FM; Farouk AM; Abdelhady SA
Egypt J Immunol; 2024 Apr; 31(2):55-60. PubMed ID: 38615235
[TBL] [Abstract][Full Text] [Related]
77. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
78. Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India.
Hans R; Marwaha N; Sharma S; Sachdev S; Sharma RR
Indian J Med Res; 2019 May; 149(5):633-640. PubMed ID: 31417031
[TBL] [Abstract][Full Text] [Related]
79. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
80. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
